These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3434464)

  • 1. [Eperisone hydrochloride in relaxation of accommodation function and improvement of eyestrain in experimental visual tasks].
    Iwasaki T; Kurimoto S
    Nippon Ganka Gakkai Zasshi; 1987 Aug; 91(8):740-6. PubMed ID: 3434464
    [No Abstract]   [Full Text] [Related]  

  • 2. Transdermal eperisone elicits more potent and longer-lasting muscle relaxation than oral eperisone.
    Yang SI; Park HY; Lee SH; Lee SJ; Han OY; Lim SC; Jang CG; Lee WS; Shin YH; Kim JJ; Lee SY
    Pharmacology; 2004 Jul; 71(3):150-6. PubMed ID: 15161997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-lasting muscle relaxant activity of eperisone hydrochloride after percutaneous administration in rats.
    Matsunaga M; Uemura Y; Yonemoto Y; Kanai K; Etoh H; Tanaka S; Atsuta Y; Nishizawa Y; Yamanishi Y
    Jpn J Pharmacol; 1997 Mar; 73(3):215-20. PubMed ID: 9127816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a centrally-acting muscle relaxant, eperisone hydrochloride, on muscle sympathetic nerve activity in humans.
    Iwase S; Mano T; Saito M; Ishida G
    Funct Neurol; 1992; 7(6):459-70. PubMed ID: 1338431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eye-strain and changes in accommodation of the eye and in visual evoked potential following quantified visual load.
    Iwasaki T; Kurimoto S
    Ergonomics; 1988 Dec; 31(12):1743-51. PubMed ID: 3234389
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological properties of the new centrally acting muscle relaxant (R)-(+)-3-phenyl-5-[2-(1-pyrrolidinylmethyl)butyryl]isoxazole hydrochloride.
    Otsu T; Kawabata H; Horikomi K; Tanada H; Sakai K; Matsubara A; Mizuchi A
    Arzneimittelforschung; 1997 Jun; 47(6):706-9. PubMed ID: 9239447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eperisone Hydrochloride, a Muscle Relaxant, Is a Potent P2X7 Receptor Antagonist.
    Okada M; Nose T
    Chem Pharm Bull (Tokyo); 2024; 72(3):345-348. PubMed ID: 38556262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of visual optical stimuli for accommodation-convergence system on asthenopia].
    Iwasaki T; Tawara A; Miyake N
    Nippon Ganka Gakkai Zasshi; 2006 Jan; 110(1):5-12. PubMed ID: 16491867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel in vitro model for screening and evaluation of anti-asthenopia drugs.
    Katsuyama I; Arakawa T
    J Pharmacol Sci; 2003 Oct; 93(2):222-4. PubMed ID: 14578593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic interactions between eperisone hydrochloride and aceclofenac: a randomized, open-label, crossover study of healthy Korean men.
    Kim MJ; Lim HS; Noh YH; Kim YH; Choi HY; Park KM; Kim SE; Bae KS
    Clin Ther; 2013 Oct; 35(10):1528-35. PubMed ID: 24050970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Myorelaxants in ophthalmology].
    Bobrova GV
    Vestn Oftalmol; 1987; 103(2):69-73. PubMed ID: 3299995
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects on eyestrain of outward stimuli for accommodation].
    Iwasaki T; Tawara A; Miyake N
    Nippon Ganka Gakkai Zasshi; 2002 Oct; 106(10):634-41. PubMed ID: 12420374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of eperisone-HCl on the stretch reflex in anesthetized cats.
    Nakajima Y; Wada N
    Jpn J Pharmacol; 1989 Dec; 51(4):572-6. PubMed ID: 2615051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of orparan and alinamin F on accommodative fatigue].
    Yamamoto K; Yoshitani Y; Kobashi T
    Nihon Ganka Kiyo; 1965 Sep; 16(9):560-5. PubMed ID: 5895273
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacology of 4'fluoro-3-(1-piperidyl) propiophenone (compound CN), a new centrally acting skeletal muscle relaxant.
    Patnaik GK; Sabir M; Dhawan BN
    Indian J Exp Biol; 1979 Apr; 17(4):397-400. PubMed ID: 489070
    [No Abstract]   [Full Text] [Related]  

  • 16. Sigma receptor modulation of the muscle relaxant action of eperisone.
    Hasegawa Y; Kaku S; Araki H; Otomo S
    Eur Neuropsychopharmacol; 1992 Jun; 2(2):157-9. PubMed ID: 1353001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the myotonolytic activity of tizanidine, eperisone and afloqualone in mouse and rabbit.
    Coward DM; White TG
    J Int Med Res; 1989; 17(4):358-62. PubMed ID: 2792555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of methylcobalamin in accommodative dysfunction of eye by visual load.
    Iwasaki T; Kurimoto S
    J UOEH; 1987 Jun; 9(2):127-32. PubMed ID: 3303247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with eperisone in the treatment of acute low back pain.
    Beltrame A; Grangiè S; Guerra L
    Minerva Med; 2008 Aug; 99(4):347-52. PubMed ID: 18663343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of eperisone and baclofen in spastic palsy: a double-blind randomized trial.
    Bresolin N; Zucca C; Pecori A
    Adv Ther; 2009 May; 26(5):563-73. PubMed ID: 19458926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.